Ixekizumab in the Treatment of Pityriasis Rubra Pilaris (PRP)

Condition:   Pityriasis Rubra Pilaris Intervention:   Drug: Ixekizumab Sponsors:   Oregon Health and Science University;   Eli Lilly and Company Not yet recruiting

Source: ClinicalTrials.gov - April 3, 2018 Category: Research Source Type: clinical trials